EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling

Markus Linder; Elisabeth Glitzner; Sriram Srivatsa; Latifa Bakiri; Kazuhiko Matsuoka; Parastoo Shahrouzi; M. Dumanic; Philipp Novoszel; Thomas Mohr; Oliver Langer; Thomas Wanek; Markus Mitterhauser; E. Wagner; Maria Sibilia

doi:10.15252/emmm.201809408

EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling

Markus Linder, Elisabeth Glitzner, Sriram Srivatsa, Latifa Bakiri, Kazuhiko Matsuoka, Parastoo Shahrouzi, M. Dumanic, Philipp Novoszel, Thomas Mohr, Oliver Langer, Thomas Wanek, Markus Mitterhauser, E. Wagner, Maria Sibilia

Medical University of Vienna

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	1
Journal	EMBO Molecular Medicine
DOIs	https://doi.org/10.15252/emmm.201809408
Publication status	Published - 2018

Research Field

Former Research Field - Health and Bioresources

Access to Document

10.15252/emmm.201809408Licence: Unspecified

Cite this

@article{e75efaa6bfbe4da787c1a3fe6a602db3,

title = "EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling",

author = "Markus Linder and Elisabeth Glitzner and Sriram Srivatsa and Latifa Bakiri and Kazuhiko Matsuoka and Parastoo Shahrouzi and M. Dumanic and Philipp Novoszel and Thomas Mohr and Oliver Langer and Thomas Wanek and Markus Mitterhauser and E. Wagner and Maria Sibilia",

year = "2018",

doi = "10.15252/emmm.201809408",

language = "English",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling

AU - Linder, Markus

AU - Glitzner, Elisabeth

AU - Srivatsa, Sriram

AU - Bakiri, Latifa

AU - Matsuoka, Kazuhiko

AU - Shahrouzi, Parastoo

AU - Dumanic, M.

AU - Novoszel, Philipp

AU - Mohr, Thomas

AU - Langer, Oliver

AU - Wanek, Thomas

AU - Mitterhauser, Markus

AU - Wagner, E.

AU - Sibilia, Maria

PY - 2018

Y1 - 2018

U2 - 10.15252/emmm.201809408

DO - 10.15252/emmm.201809408

M3 - Article

SN - 1757-4676

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

ER -